Goodman Capital is a New York-based real estate private equity firm focused on debt strategies for U.S. real estate investors and developers, including acquisition, bridge, construction, refinance, mezzanine, note-on-note and special situations lending. It is primarily relevant to real estate and finance borrowers seeking flexible debt capital, and has also participated in a Series A biotechnology/life sciences financing in the United States.